Skip to main content

This job has expired

Postdoctoral Fellow - DNA Repair and Damage

Employer
City of Hope
Location
Duarte, California
Salary
Competitive
Closing date
Feb 26, 2021

View more

Discipline
Life Sciences
Position Type
Full Time
Organization Type
Healthcare/Hospital

Job Details

About City of Hope
City of Hope, an innovative biomedical research, treatment and educational institution with over 6000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.

Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation's leading cancer centers that develops and institutes standards of care for cancer treatment.

Position Summary
Postdoctoral positions are now available in the laboratory of Dr. Terence Williams, MD, PhD in the Department of Radiation Oncology, Cancer Genetics and Epigenetics within the Beckman Research Institute of City of Hope. Applicants should be highly motivated, creative, independent fast learner, with strong work ethic and critical-thinking abilities, seeking to perform high-impact research and publish in high-impact journals. Dr. Williams' laboratory focuses on DNA repair, DNA damage response signaling, tumor metabolism, nutrient scavenging, and autophagy in multiple cancer types, including lung cancer, pancreatic cancer, thyroid cancer, colorectal cancer, brain tumors, etc. As examples of his work, Dr. Williams' lab was the first to identify a role for caveolae/Cav-1 in albumin uptake and nutrient scavenging, as well as important roles for BRAF and KRAS mutations in DNA repair and response to genotoxic therapies, including radiation. His lab actively studies caveolae-mediated endocytosis as a target for cancer therapy, how oncogenes (e.g. KRAS, BRAF) mediate resistance to therapy, how to harness cell cycle and cell cycle checkpoint repair pathways for therapeutic intent (e.g. Wee1, ATR, Chk1), developing novel RNA-based nanotherapeutics and protein-drug conjugates, and novel RNA-based signatures to predict outcomes and therapeutic response. Dr. Williams' lab research studies span across cell line modeling, animal modeling (e.g. including transgenic mouse and patient-derived models), to research with human tissues from patients with cancer.

The long-term goals of the research are to better understand the underlying molecular mechanisms of how cancer cells perform nutrient scavenging as well as how oncogenes regulate DNA repair and DNA damage response signaling after therapy, which will hopefully lead to the identification of key molecular targets that engender improvements of therapy in solid tumors. His lab is dedicated to translational research, assessing molecular alterations in cancer models and patient tissues, and obtaining novel insights from the bedside.

Qualifications
Basic education, experience and skills required for consideration:
  • A Ph.D. degree in life or biomedical sciences, or a related discipline is required.
  • Proficiency in molecular and cellular biology, biochemistry, cancer biology and/or animal (mouse) studies is required.
Additional Information:
  • Dr. Williams research is currently supported by multiple NIH R01s, American Cancer Society, Radiation Oncology Institute, Florida Biomedical Research Program, NCCN, and internal funds.
  • Research findings from Dr. Williams' research group have been published in Clinical Cancer Research, Cancer Research, Molec Cancer Therapeutics, Oncotarget, J Clin Invest, J Clin Oncology, J Thoracic Oncol, PNAS, Cancer, JAMA Surgery, IJROBP, R&O, J Biol Chem, Molec Biol Cell, Cell Cycle, and numerous other journals.
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.

#PD
#LI-CM

Company

City of Hope, an innovative biomedical research, treatment and educational institution with over 5,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.

Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research.  City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert